These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1933488)

  • 1. The EGF receptor system as a target for antitumor therapy.
    Ennis BW; Lippman ME; Dickson RB
    Cancer Invest; 1991; 9(5):553-62. PubMed ID: 1933488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro.
    Hölting T; Siperstein AE; Clark OH; Duh QY
    Eur J Endocrinol; 1995 Feb; 132(2):229-35. PubMed ID: 7858744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-alpha antibodies and tyrphostin.
    Solorzano CC; Jones SC; Pettitjean M; O'Daniel TG; Auffenberg T; Woost PG; Copeland EM; Moldawer LL; Schultz GS; MacKay SL
    Ann Surg Oncol; 1997 Dec; 4(8):670-84. PubMed ID: 9416416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
    Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
    J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
    Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
    Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TGF alpha-induced second messengers by anti-EGF receptor antibody-425.
    Murthy U; Rieman DJ; Rodeck U
    Biochem Biophys Res Commun; 1990 Oct; 172(2):471-6. PubMed ID: 2241946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of epidermal growth factor action in human myometrial smooth muscle cells.
    Környei JL; Li X; Lei ZM; Rao CV
    J Endocrinol; 1995 Aug; 146(2):261-70. PubMed ID: 7561638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
    Ahmed SR; Badger B; Wright C; Manni A
    J Steroid Biochem Mol Biol; 1991 Jun; 38(6):687-93. PubMed ID: 2064983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
    Mórocz IA; Schmitter D; Lauber B; Stahel RA
    Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
    Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
    J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise and fall of ceramide and 1,2-diacylglycerol (DAG): modulation by transforming growth factor-beta 1 (TGF beta 1) and by epidermal growth factor (EGF).
    Goldkorn T; Ding T
    Adv Exp Med Biol; 1997; 400A():461-72. PubMed ID: 9547591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture.
    Pugh JL; Sweeney WE; Avner ED
    Kidney Int; 1995 Mar; 47(3):774-81. PubMed ID: 7752576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
    Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
    J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
    Modjtahedi H; Styles JM; Dean CJ
    Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of transforming growth factor-alpha in two human colon-carcinoma cell lines.
    Watkins LF; Levine AE
    Int J Cancer; 1991 Feb; 47(3):455-60. PubMed ID: 1993555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a novel growth factor from human breast cancer cells.
    Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB
    Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
    Modjtahedi H; Komurasaki T; Toyoda H; Dean C
    Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.